Case Report

Published on 01 May 2023

B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report

in Hematologic Malignancies

Sander Eens
Manon Van Hecke
Kasper Favere
Thomas Tousseyn
Pieter-Jan Guns
Tania Roskams
Hein Heidbuchel

Frontiers in Oncology

doi 10.3389/fonc.2023.1158124

158,052 views
6 citations

Review

Published on 28 Apr 2023

Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability

in Hematologic Malignancies

Jasmine Zain
Avyakta Kallam

Frontiers in Oncology

doi 10.3389/fonc.2023.1150715

3,421 views
4 citations

Brief Research Report

Published on 28 Apr 2023

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

in Hematologic Malignancies

Adrián Mosquera Orgueira
Jose Ángel Díaz Arías
Rocio Serrano Martín
Victor Portela Piñeiro
Miguel Cid López
Andrés Peleteiro Raíndo
Laura Bao Pérez
Marta Sonia González Pérez
Manuel Mateo Pérez Encinas
Máximo Francisco Fraga Rodríguez

Frontiers in Oncology

doi 10.3389/fonc.2023.1157646

1,559 views
3 citations

Review

Published on 28 Apr 2023

Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL)

in Hematologic Malignancies

Jun Du
Shikai Jin
Minghui Zhang
Xuehang Fu
Jingwen Yang
Liwen Zhang
Zhenwei Chen
Zoufang Huang
Weisong Li
Jian Hou

Frontiers in Oncology

doi 10.3389/fonc.2023.1163190

7,379 views
2 citations

Original Research

Published on 27 Apr 2023

Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma

in Hematologic Malignancies

Yu Yang
Qing Li
Jingjing Ma
Hui Kang
Zhiguang Lin
Yang Wang
Yan Ma
Bobin Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1098785

1,425 views
3 citations

Review

Published on 26 Apr 2023

Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances

in Hematologic Malignancies

Luís Alberto de Pádua Covas Lage
Hebert Fabricio Culler
Cadiele Oliana Reichert
Sheila Aparecida Coelho da Siqueira
Juliana Pereira

Frontiers in Oncology

doi 10.3389/fonc.2023.1177590

10,846 views
10 citations

Original Research

Published on 26 Apr 2023

Misdiagnosis analysis of 2291 cases of haematolymphoid neoplasms

in Hematologic Malignancies

Jing Deng
Xiaona Zuo
Liuyi Yang
Zifen Gao
Chunju Zhou
Ligai Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1128636

2,592 views
1 citation

Original Research

Published on 25 Apr 2023

Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network

in Hematologic Malignancies

Elisabetta Antonioli
Sofia Pilerci
Irene Attucci
Gabriele Buda
Alessandro Gozzetti
Veronica Candi
Federico Simonetti
Maria Livia Del Giudice
Sara Ciofini
Michela Staderini

Frontiers in Oncology

doi 10.3389/fonc.2023.1162990

3,308 views
3 citations

Review

Published on 24 Apr 2023

Management of B-cell lineage acute lymphoblastic leukemia: expert opinion from an Indian panel via Delphi consensus method

in Hematologic Malignancies

Vikram Mathews
Anu Korula
Anupam Chakrapani
Dinesh Bhurani
Jina Bhattacharyya
Manju Sengar
Pankaj Malhotra
Pavan Kumar Boyella
Pawan Kumar Singh
Prasanth Ganesan

Frontiers in Oncology

doi 10.3389/fonc.2023.1171568

8,109 views
3 citations

Case Report

Published on 21 Apr 2023

Case Report: Co-existence of a novel EXOC4‐TRHDE gene fusion with PML-RARA in acute promyelocytic leukemia

in Hematologic Malignancies

Xiaodong Liu
Wanting Li
Jian Xiao
Huixiu Zhong
Kun Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1165819

1,273 views

Case Report

Published on 21 Apr 2023

Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis

in Hematologic Malignancies

Ester Lovato
Concetta Gangemi
Mauro Krampera
Carlo Visco
Isacco Ferrarini

Frontiers in Oncology

doi 10.3389/fonc.2023.1108994

2,107 views
2 citations

Original Research

Published on 21 Apr 2023

Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin’s disease

in Hematologic Malignancies

Mariavita Ciccarone
Paola Cavaceppi
Cristiano Tesei
Stefania Brunetti
Alessandro Pulsoni
Ombretta Annibali
Cristiano Gasparoli
Roberta Battistini
Stefan Hohaus
Sabrina Pelliccia

Frontiers in Oncology

doi 10.3389/fonc.2023.1059393

2,728 views
1 citation

Original Research

Published on 21 Apr 2023

Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma

in Hematologic Malignancies

Lukas John
Kaya Miah
Axel Benner
Elias K. Mai
Katharina Kriegsmann
Michael Hundemer
Dorothee Kaudewitz
Carsten Müller-Tidow
Karin Jordan
Hartmut Goldschmidt

Frontiers in Oncology

doi 10.3389/fonc.2023.1078725

2,668 views
2 citations

Original Research

Published on 20 Apr 2023

Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China

in Hematologic Malignancies

Zhe Zhuang
Ying Tian
Lei Shi
Dongmei Zou
Ru Feng
Wei-wei Tian
Hong Yu
Fei Dong
Aijun Liao
Yanping Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1028571

3,604 views
3 citations

Review

Published on 20 Apr 2023

Liquid biopsy in hematological malignancies: current and future applications

in Hematologic Malignancies

Donatella Talotta
Mohammad Almasri
Chiara Cosentino
Gianluca Gaidano
Riccardo Moia

Frontiers in Oncology

doi 10.3389/fonc.2023.1164517

5,380 views
10 citations

Clinical Trial

Published on 18 Apr 2023

An 8-step approach for the systematic development of an evidence-based exercise program for patients undergoing hematopoietic stem cell transplantation

in Hematologic Malignancies

Ki-Yong An
Mi-Seong Yu
Wonhee Cho
Meeok Choi
Kerry S. Courneya
June-Won Cheong
Justin Y. Jeon

Frontiers in Oncology

doi 10.3389/fonc.2023.1132776

1,968 views

Navigation group

Articles

B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report

Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL)

Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma

Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances

Misdiagnosis analysis of 2291 cases of haematolymphoid neoplasms

Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network

Management of B-cell lineage acute lymphoblastic leukemia: expert opinion from an Indian panel via Delphi consensus method

Case Report: Co-existence of a novel EXOC4‐TRHDE gene fusion with PML-RARA in acute promyelocytic leukemia

Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis

Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin’s disease

Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma

Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China

Liquid biopsy in hematological malignancies: current and future applications

An 8-step approach for the systematic development of an evidence-based exercise program for patients undergoing hematopoietic stem cell transplantation